On Friday, Shares of InterCloud Systems, Inc. (NASDAQ:ICLD), surged 17.51% to $3.96.
InterCloud Systems, will hold a conference call to talk about its financial results for the First Quarter 2015. CEO Mark Munro and CFO Tim Larkin will take part in the call, which is planned for Wednesday May 13, 2015, at 10:00 a.m. Eastern time (7:00 a.m. Pacific).
InterCloud Systems, Inc. provides end-to-end IT and network solutions to the telecommunications service provider and corporate enterprise markets through cloud platforms and professional services in the United States and internationally. It operates through three segments: Applications and Infrastructure, Professional Services, and Cloud and Managed Services.
Shares of Mylan N.V. (NASDAQ:MYL), inclined 1.31% to $71.31, during its last trading session.
Mylan, declared the launch of EpiPen® On Location™. This campaign is a national call-to-action to assist those living with potentially life-threatening (severe) allergies and their caregivers understand the importance of being prepared for a life-threatening allergic reaction (anaphylaxis) by avoiding allergic triggers and having access to two epinephrine auto-injectors, such as EpiPen® (epinephrine injection) Auto-Injectors, at all times — whether at home, school, work or on vacation. Studies reveal that nearly half of all anaphylactic episodes happen outside of the home, increasing the importance of having epinephrine in multiple locations. Epinephrine is the only first-line treatment for anaphylaxis.
To assist spread the word, three On Location Ambassadors are sharing their personal stories about managing food allergies for the first time during National Asthma and Allergy Awareness Month. Each of the Ambassadors lives with, or cares for someone with, food allergies. Captured on camera, “Project Runway” judge and Creative Director of Marie Claire Nina Garcia, Chef and cooking competition judge Amanda Freitag and “Girl Meets World” actor Auggie Maturo and his parents, talk about why it is important to be prepared should anaphylaxis occur.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
At the end of Friday’s trade, Shares of Nuance Communications, Inc. (NASDAQ:NUAN), gained 8.23% to $16.57.
Nuance Communications, declared financial results for its second quarter fiscal 2015, ended March 31, 2015.
In the second quarter of fiscal 2015, Nuance stated GAAP revenue of $475.1 million, contrast to $475.7 million in the second quarter of fiscal 2014. Nuance stated non-GAAP revenue of $488.1 million, which comprises $13.0 million of revenue lost to accounting treatment in conjunction with acquisitions, contrast to $490.0 million in the second quarter of fiscal 2014. Q2 15 revenue was negatively affected by currency fluctuations. If the company applied Q2 14 currency rates to our Q2 15 revenue, Q2 15 revenue would have been about $14 million higher.
“Nuance delivered second quarter revenue and EPS that exceeded our guidance. Our improved EPS, operating margin and operating cash flow reflect the results of our ongoing efficiency and cost control initiatives. We are also building shareholder value through renewed execution under our stock repurchase plan, which we recently raised by $500 million,” said Tom Beaudoin, Nuance CFO.
Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. It offers hosted and on-premise solutions and services that provide platforms to generate and distribute clinical documentation through the use of dictation and transcription features; clinical documentation improvement programs; and speech recognition solutions for radiology, cardiology, pathology, and related specialties enabling healthcare providers to dictate, edit, and sign reports without manual transcription.
Finally, Advanced Micro Devices, Inc. (NASDAQ:AMD), ended its last trade with -0.43% loss, and closed at $2.31.
Advanced Micro Devices, at their 2015 Financial Analyst Day is unveiling new AMD 7000 Series Accelerated Processing Units (APUs), AMD Radeon™ 300 and M300 Series Graphics, and AMD A-Series desktop APU updates, delivering a robust lineup of products in 2015 that reinforce AMD’s surround computing leadership.
“We’re excited about the experiences our latest APU and GPU technologies will bring this year for tech enthusiasts, gamers and mainstream consumers alike,” said Matt Skynner, corporate VP and general manager, Computing and Graphics Business Unit at AMD. “AMD’s commitment to graphics and compute performance is evident in the newly accessible 7000 Series APUs and the Radeon™ 300 Series graphics that deliver superior gaming experiences, premium entertainment streaming and innovative computing features.”
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company’s products primarily comprise x86 microprocessors as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs), and semi-custom System-on-Chip (SoC) products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
